#76 - Cybin CEO: Doug Drysdale on The Future of Psychedelic Treatments

#76 - Cybin CEO: Doug Drysdale on The Future of Psychedelic ...

Stigma Podcast - Mental Health

Share Podcast:
In this episode, we chat with Doug Drysdale, CEO of Cybin.  Cybin, is a life sciences company advancing mushroom based psychedelic pharmaceuticals and non-psychedelic nutraceutical products as potential therapies for psychiatric and neurological conditions. Cybin is developing technologies and delivery systems aimed at improving bioavailability to achieve the desired effects of psychedelics at low dosage levels.  Doug is an extremely accomplished...
Read More
In this episode, we chat with Doug Drysdale, CEO of Cybin.  Cybin, is a life sciences company advancing mushroom based psychedelic pharmaceuticals and non-psychedelic nutraceutical products as potential therapies for psychiatric and neurological conditions. Cybin is developing technologies and delivery systems aimed at improving bioavailability to achieve the desired effects of psychedelics at low dosage levels.  Doug is an extremely accomplished...
Read More